<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2012-01-11 19:39:10Medicine Gastroenterology Diabetes Glucagon-like peptide-1 Eli Lilly and Company Anti-diabetic medication Incretin Dipeptidyl peptidase-4 inhibitor C18 Peptide hormones Endocrine system Anti-diabetic drugs |
Add to Reading List |
Microsoft Word Viewer - Manuscript-GLP1-submission[removed]revised manuscript[removed]final.docx | Cardiovascular Pipeline April 6, 2010DocID: 1amKm - View Document |
 | 440 PRIMARY CARE DIABETOLOGY Initiating oral anti diabetic drug: alternatives to metformin Sanjay Kalra,1 Yashdeep Gupta2DocID: 118aS - View Document |
 | DIABETES MANAGEMENT IN PRACTICE Nneka Agbasi Diabetes Specialist Nurse - ECSDocID: 10wjp - View Document |
![THE PIPELINE REPORT[removed]PHARMA’S FRONTRUNNERS Profiling a dozen agents on deck](https://www.pdfsearch.io/img/6c35cc26e73c147b44c6247f82fd8351.jpg "THE PIPELINE REPORT[removed]PHARMA’S FRONTRUNNERS Profiling a dozen agents on deck") | THE PIPELINE REPORT[removed]PHARMA’S FRONTRUNNERS Profiling a dozen agents on deckDocID: RPcB - View Document |
![THE PIPELINE REPORT[removed]Latestage Standouts Spotlighting 196 agents, with profiles on 15 advances vying to be better, safer or cheaper than](https://www.pdfsearch.io/img/8cb3f1e1f4490a1953682b48b1bf97ea.jpg "THE PIPELINE REPORT[removed]Latestage Standouts Spotlighting 196 agents, with profiles on 15 advances vying to be better, safer or cheaper than") | THE PIPELINE REPORT[removed]Latestage Standouts Spotlighting 196 agents, with profiles on 15 advances vying to be better, safer or cheaper thanDocID: QHDk - View Document |